Research Grant 2024

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

About the Greg Marzolf Jr. Foundation (GMJF)

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

GMJF is dedicated to funding research grants and education programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

GMJF grants are awarded to applicants from the University of Minnesota’s MD Center. The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

Grant Program Policies and Procedures

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. We invite you to apply whether it’s your first GMJF Research Grant application or tenth, whether you are a multiple award recipient or a first-time grant writer. All are welcome. Together, we share a hope of a tomorrow free from MD!

Eligibility
Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota. While collaboration is valued and encouraged, GMJF requires all work and research to be completed within the State of Minnesota. Grant application proposals for 2024 will be due by noon on Thursday, February 15, 2024.

Purpose
The primary objective of the GMJF Research Grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Research Grant
The term of the Research Grant is a one year period with possibility of renewal research grants in subsequent years based on results. The following expenses are NOT allowed:

  • 1. Faculty(tenure or tenure-track) salary and benefits
  • 2. Secretarial salary and benefits
  • 3. Travel to scientific meetings and conferences
  • 4. Publication costs and purchase of reprints or books
  • 5. Service contracts
  • 6. Conferences, workshops, poster sessions, seminars and other meetings
  • 7. Indirect costs

Evaluation of Proposals
Applications are reviewed by MD Center faculty and the GMJF Grant Committee. The GMJF Committee will take the MD Faculty comments and align them with the research mission of the GMJF and develop a funding recommendation. Grant funding recommendations are submitted to the GMJF Board for final approval. A funding decision will be made on or before March 21, 2024. Funding decisions are also communicated to our donors to encourage additional support and revenue. We will plan to announce the donor recipients at our April 13, 2024 Gala event.

Research that involves use of human or animal subjects, biohazardous materials, etc., must be approved by the appropriate University of Minnesota committee. An application will be accepted if approval is pending, but funds will not be released in support of an award until approval has been confirmed. For further information, contact your department administrator.

Payment
Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting
Grant recipients are required to submit a brief (less than one page) progress report due October 1, 2024. Please submit this report to foundation@gregmarzolfjr.org.
This report will help us justify our funding decisions to our donors and help us promote your research to them. Failure to meet these reporting obligations will negatively impact the potential for future funding. Your progress report will be utilized to help us garner future support through email campaigns and other donor initiatives.

Application

The application form and guidelines are available at the following link:

Application form and guidelines

Evaluation Criteria

See the grant evaluation criteria at the following link:

GRANT SUBMISSION EVALUATION CRITERIA 

Research Grant

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

About the Greg Marzolf Jr. Foundation (GMJF)

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

GMJF is dedicated to funding research grants and education programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

GMJF grants are awarded to applicants from the University of Minnesota’s MD Center.  The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

Grant Program Policies and Procedures

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. We invite you to apply whether it’s your first GMJF Research Grant application or tenth, whether you are a multiple award recipient or a first-time grant writer.  All are welcome.  Together, we share a hope of a tomorrow free from MD!

Eligibility

Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota. While collaboration is valued and encouraged, GMJF requires all work and research to be completed within the State of Minnesota.

Purpose

The primary objective of the GMJF Research Grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Research Grant

The term of the Research Grant is a one year period with possibility of renewal research grants in subsequent years based on results. The following expenses are NOT allowed:

1. Faculty (tenure or tenure-track) salary and benefits

2. Secretarial salary and benefits

3. Travel to scientific meetings and conferences

4. Publication costs and purchase of reprints or books

5. Service contracts

6. Conferences, workshops, poster sessions, seminars and other meetings

7. Indirect costs

Evaluation of Proposals

Applications are reviewed by MD Center faculty and the GMJF Grant Committee. The GMJF Committee will take the MD Faculty comments and align them with the research mission of the GMJF and develop a funding recommendation.  Grant funding recommendations are submitted to the GMJF Board for final approval. A funding decision will be made on or before February 1, 2023.  Due to COVID-19, funding decisions will be communicated to grant recipients directly instead of being announced at the Cause to Cook for a Cure Gala. Funding decisions are also communicated to our donors to encourage additional support and revenue.

Research that involves use of human or animal subjects, biohazardous materials, etc., must be approved by the appropriate University of Minnesota committee. An application will be accepted if approval is pending, but funds will not be released in support of an award until approval has been confirmed. For further information, contact your department administrator.  

Payment
Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting
Grant recipients are required to submit a brief (less than one page) progress report due September 1, 2023.  Please submit this report to foundation@gregmarzolfjr.org .

This report will help us justify our funding decisions to our donors and help us promote your research to them. Failure to meet these reporting obligations will negatively impact the potential for future funding. Due to COVID-19, our fundraising efforts are more difficult, so we are looking for ways to encourage our donors to find reasons to give. Your progress report will be utilized to help us garner future support through email campaigns and other donor initiatives.

Application  

The application form and guidelines are available at the following link:

Application form and guidelines

Evaluation Criteria

See the grant evaluation criteria at the following link:

GRANT SUBMISSION EVALUATION CRITERIA 

Research Grant

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

About the Greg Marzolf Jr. Foundation (GMJF)

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

GMJF is dedicated to funding research grants and education programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

GMJF grants are awarded to applicants from the University of Minnesota’s MD Center.  The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

Grant Program Policies and Procedures

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. We invite you to apply whether it’s your first GMJF Research Grant application or tenth, whether you are a multiple award recipient or a first-time grant writer.  All are welcome.  Together, we share a hope of a tomorrow free from MD!

Eligibility

Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota. While collaboration is valued and encouraged, GMJF requires all work and research to be completed within the State of Minnesota.

Purpose

The primary objective of the GMJF Research Grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Research Grant

The term of the Research Grant is a one year period with possibility of renewal research grants in subsequent years based on results. The following expenses are NOT allowed:

1. Faculty (tenure or tenure-track) salary and benefits

2. Secretarial salary and benefits

3. Travel to scientific meetings and conferences

4. Publication costs and purchase of reprints or books

5. Service contracts

6. Conferences, workshops, poster sessions, seminars and other meetings

7. Indirect costs

Evaluation of Proposals

Applications are reviewed by MD Center faculty and the GMJF Grant Committee. The GMJF Committee will take the MD Faculty comments and align them with the research mission of the GMJF and develop a funding recommendation.  Grant funding recommendations are submitted to the GMJF Board for final approval. A funding decision will be made in December 2021.  Due to COVID-19, funding decisions will be communicated to grant recipients directly instead of being announced at the Cause to Cook for a Cure Gala. Funding decisions are also communicated to our donors to encourage additional support and revenue.

Research that involves use of human or animal subjects, biohazardous materials, etc., must be approved by the appropriate University of Minnesota committee. An application will be accepted if approval is pending, but funds will not be released in support of an award until approval has been confirmed. For further information, contact your department administrator.  

Payment
Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting
Grant recipients are required to submit a progress report due September 1, 2022.

This report will help us justify our funding decisions to our donors and help us promote your research to them. Failure to meet these reporting obligations will negatively impact the potential for future funding. Due to COVID-19, our fundraising efforts are more difficult, so we are looking for ways to encourage our donors to find reasons to give. Your progress report will be utilized to help us garner future support through email campaigns and other donor initiatives.

Application  

The application form and guidelines are available at the following link:

Application form and guidelines

Evaluation Criteria

See the grant evaluation criteria at the following link:

GRANT SUBMISSION EVALUATION CRITERIA 

Research Grant

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

About the Greg Marzolf Jr. Foundation (GMJF)

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

GMJF is dedicated to funding research grants and education programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

GMJF grants are awarded to applicants from the University of Minnesota’s MD Center.  The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

Grant Program Policies and Procedures

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. We invite you to apply whether it’s your first GMJF Research Grant application or tenth, whether you are a multiple award recipient or a first-time grant writer.  All are welcome.  Together, we share a hope of a tomorrow free from MD!

Eligibility

Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota. While collaboration is valued and encouraged, GMJF requires all work and research to be completed within the State of Minnesota.

Purpose

The primary objective of the GMJF Research Grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Research Grant

The term of the Research Grant is a one year period with possibility of renewal research grants in subsequent years based on results. The following expenses are NOT allowed:

1. Faculty (tenure or tenure-track) salary and benefits

2. Secretarial salary and benefits

3. Travel to scientific meetings and conferences

4. Publication costs and purchase of reprints or books

5. Service contracts

6. Conferences, workshops, poster sessions, seminars and other meetings

7. Indirect costs


Evaluation of Proposals

Applications are reviewed by MD Center faculty and the GMJF Grant Committee. The GMJF Committee will take the MD Faculty comments and align them with the research mission of the GMJF and develop a funding recommendation.  Grant funding recommendations are submitted to the GMJF Board for final approval. A funding decision will be made in December 2021.  Due to COVID-19, funding decisions will be communicated to grant recipients directly instead of being announced at the Cause to Cook for a Cure Gala. Funding decisions are also communicated to our donors to encourage additional support and revenue.

Research that involves use of human or animal subjects, biohazardous materials, etc., must be approved by the appropriate University of Minnesota committee. An application will be accepted if approval is pending, but funds will not be released in support of an award until approval has been confirmed. For further information, contact your department administrator.  

Payment
Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting
Grant recipients are required to submit a progress report due September 1, 2022.

This report will help us justify our funding decisions to our donors and help us promote your research to them. Failure to meet these reporting obligations will negatively impact the potential for future funding. Due to COVID-19, our fundraising efforts are more difficult, so we are looking for ways to encourage our donors to find reasons to give. Your progress report will be utilized to help us garner future support through email campaigns and other donor initiatives.

Application  

The application form and guidelines are available at the following link:

Application form and guidelines

Evaluation Criteria

See the grant evaluation criteria at the following link:

GRANT SUBMISSION EVALUATION CRITERIA 

Research Grant

GMJF_logo_11_9_15

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

General Information  

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

The Greg Marzolf Jr. Foundation (GMJF) is dedicated to funding education and research programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. Together, we share a hope of a tomorrow free from MD!

Eligibility  

Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota.

Purpose  

The primary objective of the GMJF grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. The awards will be given in the form of seed grants (Approximately $15-45K, although subject to change) to assist investigators in the early or pilot phase of their studies. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Support  

Projects are to be supported for a one year period with an anticipated start date of February 1, 2019. The following expenses are NOT allowed:

  1. Faculty (tenure or tenure-track) salary and benefits
  2. Secretarial salary and benefits
  3. Travel to scientific meetings and conferences
  4. Publication costs and purchase of reprints or books
  5. Service contracts
  6. Conferences, workshops, poster sessions, seminars and other meetings
  7. Indirect costs

Evaluation of Proposals

Applications are reviewed by a panel of experts, including MD Center faculty. The GMJF board will take the reviewers’ comments and align them with the research mission of the GMJF and make the final decision on which projects will be funded. A funding decision will be made in January and announced at the Cause to Cook for a Cure Gala on January 12th, 2019.

Payment  

Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting  

Grant recipients are required to submit a progress report due October 1, 2019. A final report is required within 30 days of grant expiration and to provide a brief on the project. Failure to meet these obligations will negatively impact the potential for future funding.  Grant recipient reports will be displayed on the Greg Marzolf Jr. Foundation website as well as distributed via newsletter to the Greg Marzolf Jr. Foundation donor base.

Application  

The application form and guidelines are available at the following link

Research Grant

GMJF_logo_11_9_15

GMJF RESEARCH GRANT PROGRAM

INFORMATION AND POLICIES

 

General Information

Founded in 2002 to commemorate the life of Greg Marzolf Jr., the Greg Marzolf Jr. Foundation’s mission is to raise awareness of Muscular Dystrophy through philanthropic activities and to support research for a cure to Muscular Dystrophy.

The Greg Marzolf Jr. Foundation (GMJF) is dedicated to funding education and research programs benefiting children and families suffering from Muscular Dystrophy and to providing support for patient service care.

The work of the GMJF has had a profound effect on the many successes of the University of Minnesota’s MD Center by enhancing treatment of this disease and patient care. With continued tenacity, the GMJF will fulfill our common goal – to conquer Muscular Dystrophy for the current generation of patients.

The GMJF is excited to continue this partnership with the GMJF Research Grant Program. Together, we share a hope of a tomorrow free from MD!

Eligibility

Eligibility is limited to advanced degree Ph.D. and/or M.D. faculty of the University of Minnesota.

Purpose

The primary objective of the GMJF grant program is to support new and existing innovative studies that focus on research in Muscular Dystrophy. The awards will be given in the form of seed grants (Approximately $35K, although subject to change) to assist investigators in the early or pilot phase of their studies. Preference will be given to those studies that focus on clinical trials and novel therapeutics for Duchenne MD.

Terms of Support

Projects are to be supported for a one year period with an anticipated start date of February 1,2017. The following expenses are NOT allowed:

a. Faculty (tenure or tenure-track) salary and benefits

b. Secretarial salary and benefits

c. Travel to scientific meetings and conferences

d. Publication costs and purchase of reprints or books

e. Service contracts

f. Conferences, workshops, poster sessions, seminars and other meetings g. Indirect costs

Evaluation of Proposals

Applications are reviewed by a panel of experts, including MD Center faculty. The GMJF board will take the reviewers’ comments and align them with the research mission of the GMJF and make the final decision on which projects will be funded. A funding decision will be made in January and announced at the Cause to Cook for a Cure Gala on January 28, 2017.

Payment

Grants will be paid to Medical School departments through invoices to UMF (non-sponsored chart strings will be established). Funds must be used within the period of the grant. After the grant expires, unexpended funds revert to GMJF UMF fund for other research projects.

Reporting

Grant recipients are required to submit a progress report due October 1, 2017. A final report is required within 30 days of grant expiration and to provide a brief on the project. Failure to meet these obligations will negatively impact the potential for future funding. Grant recipient reports will be displayed on the Greg Marzolf Jr. Foundation website as well as distributed via newsletter to the Greg Marzolf Jr. Foundation donor base.

Application

The application form and guidelines are available at the U of MN MD Center Website and also at the link below.

2017GMJFResearchGrantApplicationGuidelines

Print

University of Minnesota Making Great Strides in Research!

This story was used with permission from the University of Minnesota.

A molecular band-aid

A bleeding heart is a metaphor.

A leaking one is a common, and often deadly, reality.

In conditions from Duchenne muscular dystrophy to heart attack and heart failure, leaky heart cells lose proteins vital to long-term survival. For University of Minnesota heart researcher Joseph Metzger, fixing these leaks is a prime concern.

He is part of a U team that has built and used molecules akin to plastic as “molecular band-aids” to repair tears in the cell membranes that enclose muscle cells, keeping those vital proteins inside. Collectively, the patches are known as poloxamers.

“The FDA has approved one form of poloxamer for clinical trials with boys who have Duchenne muscular dystrophy,” says Metzger, head of the Department of Integrative Biology and Physiology. “But [we still must secure] funds for the trials.”

Metzger’s colleagues are Frank Bates, head of the Department of Chemical Engineering and Materials Science, and cardiologist Demetri Yannopoulos, an assistant professor of medicine.  Continue reading

The University of Minnesota a “powerhouse” in MD research

Congratulations to the Paul and Sheila Wellstone MD Center at the University of Minnesota for receiving three national grants from the Muscular Dystrophy Association (MDA)!

Learn more about the grants and the exciting research happening at the MD Center on the University’s HealthTalk blog. These new grants combine with three additional recent grants from the MDA for a total of over $2 million in current research support.

Nationally, the University of Minnesota ranks second of 222 institutions in the number of active research grants from the MDA.

All proceeds raised by the Greg Marzolf Jr. Foundation support local research for a cure at the Paul and Sheila Wellstone MD Center.

Marzolf Symposium celebrates advances in research

Graduate and post-doctoral students from the Paul and Sheila Wellstone MD Center presented promising research

The excitement was palpable at the fourth annual Greg Marzolf Jr. Foundation Symposium as graduate and post-doctoral students presented promising findings from their research at the University of Minnesota’s Paul and Sheila Wellstone Muscular Dystrophy Center. The event, held Oct. 29 at Nils Hasselmo Hall on the University of Minnesota’s Minneapolis campus, provided students with an opportunity to share and explain the updates and advancements they’ve discovered in their muscle research.  Continue reading

Promising Results Shared at Marzolf Symposium at U of M

Photo

Presenters are joined by Dr. John Day, Dr. Joe Metzger, Pat Marzolf and Greg Marzolf, Sr.

It was standing room only at the Second Annual Marzolf Graduate Student Symposium. Held at the Paul and Sheila Wellstone MD Center on Friday, Sept. 25, 2009 at the Nils Hasselmo Hall on the University of Minnesota Campus. This half-day program gave approximately 100 medical graduate and post-doctoral students the opportunity to share their research findings and updates of diagnostic testing done in lab settings by experts in the fields of neuro-muscular and cardiac medicine.

Dr. John Day, Director of the Wellstone Muscular Dystrophy Center and Professor of Neurology, welcomed the attendees enthusiastically, saying “All of these studies are inter-related and build on one another. These graduate level students are focused on muscular studies that will lead to treatment regimens that will result in improved length and quality of life for MD patients.”  Continue reading

Grant Recipient Profile: Lisa Anne Borgia

Lisa Anne Borgia is a recipient of the Greg Marzolf Jr. Trainee award and is currently conducting muscle research on horses, which may provide beneficial
clinic information to scientists studying muscular dystrophy. She has her master’s degree in Avian Ecology from Florida International University, and a bachelor’s of science degree in Biology and a bachelor’s of science degree in Communication from Penn State. Lisa is in her last year of the PhD program in the College of Veterinary Medicine at the University of Minnesota. She lives in Minnetrista, Minn., is married and has a 24-year-old son who is currently in law school. We asked Lisa the following questions about her research:

Q: Can you summarize your research project?

A: My research looks at the effects of dietetics (specifically oil supplementation and carbohydrate content) on horses with a neuromuscular disease called Polysaccharide Storage myopathy, as well as muscle energetics in normal horses and the effect of training on normal muscle tissue.  Continue reading